MHCombiotic Inc. (MHC)
MHCombiotic Inc. (MHC) is helping to save tens of thousands of lives by formulating novel and safe antibacterial agents with a very low chance of future resistance.
This is an internation group from University of Calgary (Calgary, Canada), University of Harvard (US), as well as private pharma lab teams (Montreal, Canada) for discovering novel antimicrobial.
Our team members have more than 25 years of experience on antibiotic resistance and antimicrobial discovery.
Our team combines decades of state-of-the-art Antimicrobial Resistance (AMR) elimination scientific research – having conducted over 10,000 tests in the last 2 years – with world-leading subject experts, top universities, and private pharma lab teams, to discover the most efficacious and cost-effective solution to deploy globally and urgently.
With our world-class facilities and our extensive academic, and scientific experience, we are discovering novel and safe antimicrobials with different properties and expenditures.
We provide consulting to industries regarding antimicrobials and biocides to address their microbial/biofilm/biofouling challenges.
We are the ideal strategic partner and supplier of innovation and R&D support.
We are pioneer in research, innovation and prototype development in many industrial and clinical sectors.
We help companies develop new hypotheses, products and also services which are often not part of their core expertise.